HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhen Li Selected Research

member 1 small inducible cytokine subfamily E

1/2018Endothelial Monocyte-Activating Polypeptide-II Induces BNIP3-Mediated Mitophagy to Enhance Temozolomide Cytotoxicity of Glioma Stem Cells via Down-Regulating MiR-24-3p.
1/2018MiR-429 Regulated by Endothelial Monocyte Activating Polypeptide-II (EMAP-II) Influences Blood-Tumor Barrier Permeability by Inhibiting the Expressions of ZO-1, Occludin and Claudin-5.
1/2017Combination of Endothelial-Monocyte-Activating Polypeptide-II with Temozolomide Suppress Malignant Biological Behaviors of Human Glioblastoma Stem Cells via miR-590-3p/MACC1 Inhibiting PI3K/AKT/mTOR Signal Pathway.
1/2017The Role of miR-330-3p/PKC-α Signaling Pathway in Low-Dose Endothelial-Monocyte Activating Polypeptide-II Increasing the Permeability of Blood-Tumor Barrier.
1/2017Endothelial-Monocyte Activating Polypeptide II Suppresses the In Vitro Glioblastoma-Induced Angiogenesis by Inducing Autophagy.
6/2016Low-Dose Endothelial Monocyte-Activating Polypeptide-II Increases Blood-Tumor Barrier Permeability by Activating the RhoA/ROCK/PI3K Signaling Pathway.
2/2016Low-Dose Endothelial Monocyte-Activating Polypeptide-II Induces Blood-Tumor Barrier Opening Via the cAMP/PKA/Rac1 Pathway.
9/2015Roles of Serine/Threonine Phosphatases in Low-Dose Endothelial Monocyte-Activating Polypeptide-II-Induced Opening of Blood-Tumor Barrier.
9/2015Functions for the cAMP/Epac/Rap1 Signaling Pathway in Low-Dose Endothelial Monocyte-Activating Polypeptide-II-Induced Opening of Blood-Tumor Barrier.
5/2015Role of cAMP-dependent protein kinase A activity in low-dose endothelial monocyte-activating polypeptide-II-induced opening of blood-tumor barrier.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhen Li Research Topics

Disease

361Neoplasms (Cancer)
11/2022 - 03/2002
74Infections
12/2022 - 07/2002
60Glioma (Gliomas)
07/2022 - 01/2011
58Inflammation (Inflammations)
07/2022 - 10/2002
49Neoplasm Metastasis (Metastasis)
11/2022 - 04/2007
46Breast Neoplasms (Breast Cancer)
01/2022 - 06/2005
33Carcinogenesis
11/2022 - 09/2008
33Pain (Aches)
11/2022 - 06/2005
30Hepatocellular Carcinoma (Hepatoma)
04/2022 - 04/2007
28Fibrosis (Cirrhosis)
10/2022 - 07/2005
27Glioblastoma (Glioblastoma Multiforme)
10/2022 - 01/2012
26Carcinoma (Carcinomatosis)
05/2022 - 07/2004
20Hypersensitivity (Allergy)
01/2021 - 05/2004
19Stomach Neoplasms (Stomach Cancer)
12/2022 - 01/2010
19Obesity
01/2022 - 04/2005
19Reperfusion Injury
01/2022 - 01/2005
18Atherosclerosis
01/2022 - 11/2004
18Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 04/2013
18Prostatic Neoplasms (Prostate Cancer)
01/2022 - 04/2009
17Lung Neoplasms (Lung Cancer)
01/2022 - 01/2012
17Body Weight (Weight, Body)
08/2021 - 12/2002
17Ischemia
06/2021 - 01/2005
16Heart Failure
07/2022 - 01/2015
16Wounds and Injuries (Trauma)
04/2022 - 04/2006
14Hypoxia (Hypoxemia)
10/2022 - 01/2005
14Asthma (Bronchial Asthma)
01/2022 - 11/2009
14Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2021 - 05/2015
13Type 2 Diabetes Mellitus (MODY)
01/2022 - 09/2012
13Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 03/2016
12Leukemia
04/2022 - 01/2013
12Insulin Resistance
01/2021 - 04/2005
11COVID-19
05/2022 - 01/2020
11Adenocarcinoma
12/2021 - 10/2013
11Melanoma (Melanoma, Malignant)
11/2021 - 01/2001
10Brain Ischemia (Cerebral Ischemia)
08/2022 - 10/2008
10Cardiovascular Diseases (Cardiovascular Disease)
07/2022 - 01/2012
10Thrombosis (Thrombus)
01/2022 - 05/2013
9Sepsis (Septicemia)
12/2022 - 09/2013
9Alzheimer Disease (Alzheimer's Disease)
08/2022 - 06/2009
9Cognitive Dysfunction
06/2022 - 06/2009
9Osteoarthritis
01/2022 - 03/2016
9Pneumonia (Pneumonitis)
01/2022 - 04/2014
9Colonic Neoplasms (Colon Cancer)
12/2021 - 04/2015
8Ovarian Neoplasms (Ovarian Cancer)
11/2022 - 05/2014
8Human Influenza (Influenza)
01/2022 - 04/2011

Drug/Important Bio-Agent (IBA)

119Proteins (Proteins, Gene)FDA Link
11/2022 - 10/2003
66Pharmaceutical PreparationsIBA
08/2022 - 06/2005
66Biomarkers (Surrogate Marker)IBA
06/2022 - 04/2009
60Biological ProductsIBA
01/2022 - 02/2011
48Long Noncoding RNAIBA
01/2022 - 02/2015
47MicroRNAs (MicroRNA)IBA
08/2022 - 01/2007
38Messenger RNA (mRNA)IBA
01/2022 - 01/2005
32Therapeutic UsesIBA
09/2022 - 04/2012
30RNA (Ribonucleic Acid)IBA
01/2022 - 01/2008
29CytokinesIBA
12/2022 - 11/2008
17DNA (Deoxyribonucleic Acid)IBA
04/2022 - 03/2002
17member 1 small inducible cytokine subfamily EIBA
01/2018 - 01/2011
16EnzymesIBA
07/2022 - 04/2005
16CollagenIBA
01/2022 - 07/2005
15Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2010
14Reactive Oxygen Species (Oxygen Radicals)IBA
10/2022 - 01/2011
14Doxorubicin (Adriamycin)FDA LinkGeneric
09/2021 - 01/2012
13Small Interfering RNA (siRNA)IBA
01/2022 - 04/2009
13LipidsIBA
01/2022 - 10/2002
13Transcription Factors (Transcription Factor)IBA
01/2022 - 03/2013
13Contrast MediaIBA
03/2020 - 04/2011
11RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2022 - 01/2018
10Circular RNAIBA
11/2022 - 01/2018
10Cisplatin (Platino)FDA LinkGeneric
08/2022 - 02/2017
10Hydrogen Sulfide (Sulfide, Hydrogen)IBA
01/2022 - 08/2015
10Phosphotransferases (Kinase)IBA
01/2022 - 01/2010
10PolymersIBA
01/2022 - 01/2010
10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2021 - 06/2009
10Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019 - 02/2004
9LipopolysaccharidesIBA
06/2022 - 02/2006
9Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2022 - 01/2013
9AntibodiesIBA
01/2022 - 01/2017
9Peptides (Polypeptides)IBA
06/2021 - 04/2009
9Neuroprotective AgentsIBA
01/2020 - 01/2005
9CateninsIBA
08/2019 - 02/2011
9Bee Venoms (Bee Venom)IBA
04/2016 - 06/2004
8LigandsIBA
07/2022 - 01/2015
8Capsules (Microcapsules)IBA
05/2022 - 01/2014
81-phenyl-3,3-dimethyltriazene (PDT)IBA
02/2022 - 10/2018
8Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 01/2015
8Indicators and Reagents (Reagents)IBA
01/2022 - 02/2011
8VaccinesIBA
01/2022 - 05/2004
8Interleukin-6 (Interleukin 6)IBA
01/2022 - 12/2007

Therapy/Procedure

159Therapeutics
11/2022 - 07/2005
46Drug Therapy (Chemotherapy)
10/2022 - 12/2004
17Radiotherapy
10/2022 - 07/2002
17Lasers (Laser)
09/2022 - 11/2010
16Stents
10/2022 - 01/2007
14Immunotherapy
10/2022 - 02/2014
12Photochemotherapy (Photodynamic Therapy)
02/2022 - 03/2015
12Photothermal Therapy
10/2020 - 04/2016
11Chinese Traditional Medicine (Traditional Chinese Medicine)
04/2022 - 08/2013
11Transplantation
01/2022 - 05/2002
10Hematopoietic Stem Cell Transplantation
01/2022 - 01/2014
8Precision Medicine
01/2022 - 04/2016